Cargando…
Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical Applications
Although there are only two bispecific antibody (bsAb) drugs in the market, around 100 bsAb drug candidates are in clinical development. bsAbs have gained fast growing investment and attractions from the biopharmaceutical industry and academia in recent years. Antibody Engineering and Therapeutics 2...
Autores principales: | Zhu, Yong, Shen, Run, Hao, Rui, Wang, Shouye, Ho, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363406/ https://www.ncbi.nlm.nih.gov/pubmed/32671329 http://dx.doi.org/10.1093/abt/tbaa012 |
Ejemplares similares
-
Antibody engineering & therapeutics, the annual meeting of the antibody society December 7–10, 2015, San Diego, CA, USA
por: Pauthner, Matthias, et al.
Publicado: (2016) -
Highlights of 2019 Protein Engineering Summit (PEGS) in Boston, USA: advancing antibody-based cancer therapies to the clinic
por: Li, Hong, et al.
Publicado: (2019) -
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11–15, 2016, San Diego, CA
por: Larrick, James W., et al.
Publicado: (2016) -
PHO 2019 Conference Abstracts: San Diego, CA, USA. 25-26 October 2019
Publicado: (2019) -
IBC's 21(st) Annual Antibody Engineering and 8(th) Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of The Antibody Society: December 5–9, 2010, San Diego, CA USA
por: Arnett, Samantha O, et al.
Publicado: (2011)